Prima Sanjiwani Saraswati Sudarsa, Mario Korwa, & Nyoman Suryawati. (2026). Therapeutic Outcomes of Secukinumab 300 mg in Severe Psoriasis Vulgaris with Metabolic Comorbidities: A Retrospective Cohort Study in Bali. Bioscientia Medicina : Journal of Biomedicine and Translational Research, 10(4), 1048-1096. https://doi.org/10.37275/bsm.v10i4.1552